HeartBeam study shows ECG device may help assess heart attack risk at home

Go back to HeartBeam study shows ECG device may help assess heart attack risk at home
BIOTELEMETRY (NASDAQ: BEAT) Delayed: 0.71 -0.05 (6.58%)
Previous Close $0.76    52 Week High $21.68 
Open $0.74    52 Week Low $8.74 
Day High $0.77    P/E N/A 
Day Low $0.71    EPS $-0.46 
Volume 466,475